Group, for the GI-4000 in Pancreas Cancer Study
Mayo Clinic
No affiliation available
Citations 1
A Phase 2 Randomized Placebo-Controlled Adjuvant Trial of GI-4000, a Recombinant Yeast Expressing Mutated RAS Proteins in Patients with Resected Pancreas Cancer
Muscarella, Peter , McIntyre, Kristi , Rosemurgy, Alexander S. , Ross, Sharona , Richards, Donald , Fisher, William E., Flynn, Patrick J. , Mattson, Alicia, Coeshott, Claire, Roder, Joanna , Cohn, Allen Lee, Rodell, Timothy C., Apelian, David, Group, for the GI-4000 in Pancreas Cancer Study, Bekaii‐Saab, Tanios , Röder, Heinrich , Harrell, Frank E. , Group, for the GI-4000 in Pancreas Cancer Study
Journal of Pancreatic Cancer | March 24, 2021 | Volume: 7 | Issue: 1 | Pages: 8-19
